188 related articles for article (PubMed ID: 26640079)
1. Ketamine-based procedural sedation and analgesia for botulinum toxin A injections in children with cerebral palsy.
Chow C; Choong CT
Eur J Paediatr Neurol; 2016 Mar; 20(2):319-322. PubMed ID: 26640079
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of a Propofol and Ketamine Based Procedural Sedation Protocol in Children with Cerebral Palsy Undergoing Botulinum Toxin A Injections.
Louer R; McKinney RC; Abu-Sultaneh S; Lutfi R; Abulebda K
PM R; 2019 Dec; 11(12):1320-1325. PubMed ID: 30761757
[TBL] [Abstract][Full Text] [Related]
3. A rectally administered combination of midazolam and ketamine was easy, effective and feasible for procedural pain in children with cerebral palsy.
Nilsson S; Brunsson I; Askljung B; Påhlman M; Himmelmann K
Acta Paediatr; 2017 Mar; 106(3):458-462. PubMed ID: 27992073
[TBL] [Abstract][Full Text] [Related]
4. Safe and efficacious use of procedural sedation and analgesia by nonanesthesiologists in a pediatric emergency department.
Pitetti RD; Singh S; Pierce MC
Arch Pediatr Adolesc Med; 2003 Nov; 157(11):1090-6. PubMed ID: 14609900
[TBL] [Abstract][Full Text] [Related]
5. Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Roback MG; Wathen JE; Bajaj L; Bothner JP
Acad Emerg Med; 2005 Jun; 12(6):508-13. PubMed ID: 15930401
[TBL] [Abstract][Full Text] [Related]
6. [Sedation-analgesia protocol for the injection of botulinum toxin A in cerebral palsy].
Cantador-Hornero M; Jiménez-Espuch P; de Torres-Garcia I; Contreras-Jiménez M; Martínez-Mezo GL; Morales de Los Santos JM; Fernández-Jurado MI; Tirado-Reyes M
An Pediatr (Engl Ed); 2019 Nov; 91(5):317-327. PubMed ID: 30795881
[TBL] [Abstract][Full Text] [Related]
7. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
Lorin K; Forsberg A
Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
[TBL] [Abstract][Full Text] [Related]
8. [Sevoflurane sedation protocol in children with cerebral palsy undergoing botulinum toxin-A injections].
León-Valenzuela A; Román Malo C; González López M; Sánchez Palacios J; Sánchez Tarifa P; Del Pino Algarrada R
Rehabilitacion (Madr); 2021; 55(4):266-272. PubMed ID: 33468348
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
10. 'Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children'.
Gubbay A; Langdon K
Dev Med Child Neurol; 2009 Jun; 51(6):491-2; author reply 492. PubMed ID: 19416317
[No Abstract] [Full Text] [Related]
11. The key-muscle concept: a long-term low-dose injection strategy for botulinum toxin A treatment in cerebral palsy.
Placzek R; Salem KH; Meiss LA; Siebold D; Drescher W
Acta Orthop Belg; 2012 Feb; 78(1):111-6. PubMed ID: 22523937
[TBL] [Abstract][Full Text] [Related]
12. Systemic adverse events after botulinum neurotoxin A injections in children with cerebral palsy.
Paget SP; Swinney CM; Burton KLO; Bau K; O'Flaherty SJ
Dev Med Child Neurol; 2018 Nov; 60(11):1172-1177. PubMed ID: 30146721
[TBL] [Abstract][Full Text] [Related]
13. Should botulinum toxin A injections be repeated in children with cerebral palsy? A systematic review.
Kahraman A; Seyhan K; Değer Ü; Kutlutürk S; Mutlu A
Dev Med Child Neurol; 2016 Sep; 58(9):910-7. PubMed ID: 27103334
[TBL] [Abstract][Full Text] [Related]
14. Use of midazolam and ketamine as sedation for children undergoing minor operative procedures.
Cheuk DK; Wong WH; Ma E; Lee TL; Ha SY; Lau YL; Chan GC
Support Care Cancer; 2005 Dec; 13(12):1001-9. PubMed ID: 15846522
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children.
Zier JL; Rivard PF; Krach LE; Wendorf HR
Dev Med Child Neurol; 2008 Nov; 50(11):854-8. PubMed ID: 19046178
[TBL] [Abstract][Full Text] [Related]
16. A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19).
McLaughlin MJ; Fisher MT; Vadivelu S; Ramsey J; Ratnasingam D; McGhee E; Hartman K
J Pediatr Rehabil Med; 2020; 13(3):273-279. PubMed ID: 33252098
[TBL] [Abstract][Full Text] [Related]
17. Safe and efficacious use of procedural sedation and analgesia by non-anesthesiologists in a pediatric hematology-oncology unit.
Borker A; Ambulkar I; Gopal R; Advani SH
Indian Pediatr; 2006 Apr; 43(4):309-14. PubMed ID: 16651669
[TBL] [Abstract][Full Text] [Related]
18. Validity of bispectral index monitoring during deep sedation in children with spastic cerebral palsy undergoing injection of botulinum toxin.
Jung SM; Lee E; Park SJ
Korean J Anesthesiol; 2019 Dec; 72(6):592-598. PubMed ID: 31378054
[TBL] [Abstract][Full Text] [Related]
19. Does midazolam alter the clinical effects of intravenous ketamine sedation in children? A double-blind, randomized, controlled, emergency department trial.
Wathen JE; Roback MG; Mackenzie T; Bothner JP
Ann Emerg Med; 2000 Dec; 36(6):579-88. PubMed ID: 11097698
[TBL] [Abstract][Full Text] [Related]
20. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
